Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysisResearch and Practice in Thrombosis and Haemostasis, 2020-10, Vol.4 (7), p.1178-1191 [Peer Reviewed Journal]2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH). ;2020 The Authors. published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH). ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2475-0379 ;EISSN: 2475-0379 ;DOI: 10.1002/rth2.12439 ;PMID: 33043231Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapyBlood, 2021-03, Vol.137 (12), p.1669-1678 [Peer Reviewed Journal]2021 American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020007878 ;PMID: 33067632Full text available |
|
3 |
Material Type: Article
|
Cancer-associated venous thromboembolismNature reviews. Disease primers, 2022-02, Vol.8 (1), p.11-11, Article 11 [Peer Reviewed Journal]2022. Springer Nature Limited. ;Springer Nature Limited 2022. ;ISSN: 2056-676X ;EISSN: 2056-676X ;DOI: 10.1038/s41572-022-00336-y ;PMID: 35177631Full text available |
|
4 |
Material Type: Article
|
Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trialsResearch and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.550-561 [Peer Reviewed Journal]2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. ;2020 The Authors. published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2475-0379 ;EISSN: 2475-0379 ;DOI: 10.1002/rth2.12359 ;PMID: 32548553Full text available |
|
5 |
Material Type: Article
|
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with CancerInternational journal of molecular sciences, 2022-12, Vol.23 (24), p.15770 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms232415770 ;PMID: 36555414Full text available |
|
6 |
Material Type: Article
|
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysisScientific reports, 2019-04, Vol.9 (1), p.5548, Article 5548 [Peer Reviewed Journal]The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-019-42069-1 ;PMID: 30944390Full text available |
|
7 |
Material Type: Article
|
Risk assessment for recurrent venous thromboembolism in patients with cancerThrombosis update, 2021-12, Vol.5, p.100080, Article 100080 [Peer Reviewed Journal]2021 The Authors ;ISSN: 2666-5727 ;EISSN: 2666-5727 ;DOI: 10.1016/j.tru.2021.100080Full text available |
|
8 |
Material Type: Article
|
Risk assessment models of cancer-associated thrombosis - Potentials and perspectivesThrombosis update, 2021-12, Vol.5, p.100075, Article 100075 [Peer Reviewed Journal]2021 The Authors ;ISSN: 2666-5727 ;EISSN: 2666-5727 ;DOI: 10.1016/j.tru.2021.100075Full text available |
|
9 |
Material Type: Article
|
Alterations of the Platelet Proteome in Lung Cancer: Accelerated F13A1 and ER Processing as New Actors in HypercoagulabilityCancers, 2021-05, Vol.13 (9), p.2260 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers13092260 ;PMID: 34066760Full text available |
|
10 |
Material Type: Article
|
Outpatient Pulmonary Rehabilitation in Patients with Persisting Symptoms after Pulmonary EmbolismJournal of clinical medicine, 2020-06, Vol.9 (6), p.1811 [Peer Reviewed Journal]2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm9061811 ;PMID: 32532020Full text available |
|
11 |
Material Type: Article
|
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapyScientific reports, 2020-07, Vol.10 (1), p.11219, Article 11219 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-68010-5 ;PMID: 32641710Full text available |
|
12 |
Material Type: Article
|
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerBlood advances, 2021-01, Vol.5 (2), p.487-495 [Peer Reviewed Journal]2021 The American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 2473-9529 ;EISSN: 2473-9537 ;DOI: 10.1182/bloodadvances.2020003149 ;PMID: 33496742Full text available |
|
13 |
Material Type: Article
|
Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis StudyCancers, 2020-09, Vol.12 (9), p.2493 [Peer Reviewed Journal]COPYRIGHT 2020 MDPI AG ;2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers12092493 ;PMID: 32899157Full text available |
|
14 |
Material Type: Article
|
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemicESMO Open, 2020-09, Vol.5 (5), p.e000889-e000889, Article e000889 [Peer Reviewed Journal]Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. ;2020 © 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. 2020 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1136/esmoopen-2020-000889 ;PMID: 32878898Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancerFrontiers in cardiovascular medicine, 2022-08, Vol.9, p.933428-933428 [Peer Reviewed Journal]Copyright © 2022 Posch, Niedrist, Glantschnig, Firla, Moik, Kolesnik, Wallner, Verheyen, Jost, Zirlik, Pichler, Balic and Rainer. 2022 Posch, Niedrist, Glantschnig, Firla, Moik, Kolesnik, Wallner, Verheyen, Jost, Zirlik, Pichler, Balic and Rainer ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2022.933428 ;PMID: 36051281Full text available |
|
16 |
Material Type: Article
|
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyJournal for immunotherapy of cancer, 2023-12, Vol.11 (12), p.e007765 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2023-007765 ;PMID: 38097343Full text available |
|
17 |
Material Type: Article
|
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with gliomaESMO open, 2020-05, Vol.5 (3), p.e000647-e000647, Article e000647 [Peer Reviewed Journal]Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. ;2020 © 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology. ;Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. 2020 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1136/esmoopen-2019-000647 ;PMID: 32424065Full text available |
|
18 |
Material Type: Article
|
VTE with Amivantamab plus Chemotherapy in NSCLCThe New England journal of medicine, 2024-02, Vol.390 (6), p.578-580 [Peer Reviewed Journal]Copyright © 2024 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2314937 ;PMID: 38324502Full text available |
|
19 |
Material Type: Article
|
Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of LifeRespiration, 2022-06, Vol.101 (6), p.593-601 [Peer Reviewed Journal]2022 The Author(s). Published by S. Karger AG, Basel ;2022. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. ;ISSN: 0025-7931 ;EISSN: 1423-0356 ;DOI: 10.1159/000522118 ;PMID: 35203084Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerHaematologica (Roma), 2024-04, Vol.109 (4), p.1128-1136 [Peer Reviewed Journal]Copyright© 2024 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.283581 ;PMID: 37822244Full text available |